1.
Konté K, Swinkels DW, Budde IK, Nur E, Biemond BJ. Safety and efficacy of human apotransferrin infusion in patients with β-thalassemia intermedia: the AIM study. haematol [Internet]. 2020Sep.10 [cited 2024Dec.22];. Available from: https://haematologica.org/article/view/haematol.2024.285045